Onuma TE

Language: Spanish
References: 8
Page: 3-4
PDF size: 102.30 Kb.

REFERENCES

1. Muraro A, Lemanske RF Jr, Castells M, Torres MJ, Khan D, Simon HU et al. Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. Allergy. 2017; 72 (7): 1006-1021.

2. Ferrando M, Bagnaso D, Varricchi F, Bernardi S, Bragnatini A, Passalacqua G et al. Personalized medicine in allergy. Allergy Asthma Immunol Res. 2017; 9 (1): 15-24.

3. Nimmesgern E. Europ personalized medicine in Europe. Clin Transi Sci. 2017; 10: 61-63.

4. Agache I. Untangling asthma phenotypes and endotypes. Allergy. 2012; 67 (7): 835-846.

5. Teri M. Asthma management: a new phenotype-based approach using presence of eosinophilia and allergy. Allergy. 2017; 72 (9): 1279-1287.

6. De Bruin-Weller M, Thaci D, Smith CH, Cork M, Radin A, Zhang Q et al. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with inadequate or intolerance to ciclosporin A or when this treatment I medically inadvisable. Br J Dermatol. 2018; 178: 1083-1101.

7. Corre J. Efficacy of tezepelumab in patients with evidence of server allergy asthma: results from the phase 3 NAVIGATOR study. Clin Exp Allergy. 2023; 53 (4): 417-428.

8. Szilveazter KP, Németh T, Mocsai A. Tyrosine kinases in autoimmune and inflammatory skin disease. Front Immunol. 2019; 10: 1862.